Graphene Quantum Dots Show Promise in Targeting Parkinson's-Related Protein Clumping

Researchers have discovered that graphene quantum dots can effectively target and disrupt the toxic clumping of alpha-synuclein proteins associated with Parkinson's disease. This breakthrough could lead to new treatments for the condition. The implications are significant for medical science and potential therapies.